Blaž Trotovšek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Blaž Trotovšek has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Miha Petrič
Department of Abdominal Surgery, University Medical Centre Ljubljana, Zaloška 7, 1000 Ljubljana, Slovenia
11 shared publications - Mihajlo Djokic
Department of Abdominal Surgery, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia
10 shared publications - Aleš Tomažič
Department of Abdominal Surgery, University Medical Centre Ljubljana, Zaloška Cesta 7, 1000 Ljubljana, Slovenia
5 shared publications - Jan Grosek
Department of Abdominal Surgery, University Medical Center Ljubljana, Zaloska 7, 1000 Ljubljana, Slovenia
5 shared publications - Gregor Sersa
Institute of Oncology Ljubljana
4 shared publications - Boštjan Plešnik
Department of Abdominal Surgery, University Medical Center Ljubljana, Zaloska 7, 1000 Ljubljana, Slovenia
3 shared publications
Latest Publications
- Open Access
Perioperative H-FABP and Its Association with Postoperative Morbidity Following Pancreatic Resection: A Prospective Observational Study
Background and Objectives: Postoperative morbidity presents a significant challenge in pancreatic surgery. Biomarkers that enable early detection of complications could enhance postoperative monitoring and allow for timely intervention. This study aimed to assess whether perioperative concentrations of heart-type fatty acid–binding protein (H-FABP) are linked to severe postoperative complications and pancreas-specific morbidity following pancreatic resection. Materials and Methods: Serum H-FABP levels were measured preoperatively and on postoperative days 2, 4, and 6. Results: Among the 53 patients (33 women [62.3%]) included in the final analysis, those with malignant disease exhibited significantly higher preoperative H-FABP concentrations (median, 1320 vs. 630 ng/L; p = 0.015), as did patients classified as ASA III (median, 1309 vs. 620 ng/L; p = 0.025) and aged 70 years or older (median = 1431 vs. 550 ng/L; p < 0.001). Elevated postoperative H-FABP levels were associated with severe complications, with notable increases observed on postoperative day (POD) 2 (p = 0.026), POD4 (p = 0.022), and POD6 (p = 0.015). Exploratory ROC analysis indicated moderate discrimination for severe complications (AUC, 0.70, 0.71, and 0.73, respectively). No significant differences in postoperative H-FABP levels were found among patients with clinically relevant postoperative pancreatic fistula, postpancreatectomy acute pancreatitis and postpancreatectomy hemorrhage. Conclusions: Exploratory comparisons at individual time points showed higher postoperative concentrations of H-FABP in patients with severe complications; however, the main longitudinal analysis using a mixed-effects model did not reveal a statistically significant group effect or an interaction between group and time. Larger prospective multicenter studies are required to validate its clinical utility.
Open AccessPerioperative H-FABP and Its Association with Postoperative Morbidity Following Pancreatic Resection: A Prospective Observational Study
Background and Objectives: Postoperative morbidity presents a significant challenge in pancreatic surgery. Biomarkers that enable early detection of complications could enhance postoperative monitoring and allow for timely intervention. This study aimed to assess whether perioperative concentrations of heart-type fatty acid–binding protein (H-FABP) are linked to severe postoperative complications and pancreas-specific morbidity following pancreatic resection. Materials and Methods: Serum H-FABP levels were measured preoperatively and on postoperative days 2, 4, and 6. Results: Among the 53 patients (33 women [62.3%]) included in the final analysis, those with malignant disease exhibited significantly higher preoperative H-FABP concentrations (median, 1320 vs. 630 ng/L; p = 0.015), as did patients classified as ASA III (median, 1309 vs. 620 ng/L; p = 0.025) and aged 70 years or older (median = 1431 vs. 550 ng/L; p < 0.001). Elevated postoperative H-FABP levels were associated with severe complications, with notable increases observed on postoperative day (POD) 2 (p = 0.026), POD4 (p = 0.022), and POD6 (p = 0.015). Exploratory ROC analysis indicated moderate discrimination for severe complications (AUC, 0.70, 0.71, and 0.73, respectively). No significant differences in postoperative H-FABP levels were found among patients with clinically relevant postoperative pancreatic fistula, postpancreatectomy acute pancreatitis and postpancreatectomy hemorrhage. Conclusions: Exploratory comparisons at individual time points showed higher postoperative concentrations of H-FABP in patients with severe complications; however, the main longitudinal analysis using a mixed-effects model did not reveal a statistically significant group effect or an interaction between group and time. Larger prospective multicenter studies are required to validate its clinical utility.
- Open Access
- 1 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6778
Early Adoption of Technically Complex Robotic Ventral Hernia Repair in a Low-Volume Center: A Retrospective Comparative Analysis with Consecutive Open Cases
Background/Objectives: Robotic-assisted abdominal wall reconstruction is increasingly used for ventral hernias; however, implementation in low-volume settings and early adoption of technically complex cases remain controversial. This study aimed to evaluate perioperative outcomes of robotic ventral hernia repair with early inclusion of technically complex cases and to compare these results with open surgery. Methods: Prospectively collected data were retrospectively analyzed for consecutive technically complex robotic ventral hernia repairs performed between September 2021 and December 2025. A cohort of consecutive open Rives–Stoppa repairs was included for comparison (n = 21 per group). Outcomes included operative time, length of hospital stay (LOS), and perioperative complications. Results: Operative time was significantly longer in the robotic group (median 310 vs. 118 min, p < 0.001). The median LOS was significantly shorter following robotic repair (3 vs. 5 days, p = 0.0018). Postoperative complications occurred in 10% of robotic cases and 24% of open cases (p = 0.41). Major complications and reoperation rates were low and comparable between groups. Technically complex robotic cases, including procedures requiring component separation, were introduced early and were associated with acceptable short-term outcomes. Conclusions: Technically complex robotic hernia repair was associated with significantly shorter hospital stay compared with open surgery, despite longer operative times and higher procedural complexity. Complication rates were comparable between groups. Early inclusion of technically complex cases was not associated with a statistically significant increase in short-term complications.
- 1 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6778
Open AccessEarly Adoption of Technically Complex Robotic Ventral Hernia Repair in a Low-Volume Center: A Retrospective Comparative Analysis with Consecutive Open Cases
Background/Objectives: Robotic-assisted abdominal wall reconstruction is increasingly used for ventral hernias; however, implementation in low-volume settings and early adoption of technically complex cases remain controversial. This study aimed to evaluate perioperative outcomes of robotic ventral hernia repair with early inclusion of technically complex cases and to compare these results with open surgery. Methods: Prospectively collected data were retrospectively analyzed for consecutive technically complex robotic ventral hernia repairs performed between September 2021 and December 2025. A cohort of consecutive open Rives–Stoppa repairs was included for comparison (n = 21 per group). Outcomes included operative time, length of hospital stay (LOS), and perioperative complications. Results: Operative time was significantly longer in the robotic group (median 310 vs. 118 min, p < 0.001). The median LOS was significantly shorter following robotic repair (3 vs. 5 days, p = 0.0018). Postoperative complications occurred in 10% of robotic cases and 24% of open cases (p = 0.41). Major complications and reoperation rates were low and comparable between groups. Technically complex robotic cases, including procedures requiring component separation, were introduced early and were associated with acceptable short-term outcomes. Conclusions: Technically complex robotic hernia repair was associated with significantly shorter hospital stay compared with open surgery, despite longer operative times and higher procedural complexity. Complication rates were comparable between groups. Early inclusion of technically complex cases was not associated with a statistically significant increase in short-term complications.
- Open Access
- 3 August 2026
- Published by MDPI AG in Preprints.org
Early Adoption of Complex Robotic Ventral Hernia Repair in a Low-Volume Center: A Retrospective Comparative Analysis with Consecutive Open Cases
Background/Objectives: Robotic-assisted abdominal wall reconstruction is increasingly used for complex ventral hernias; however, implementation in low-volume settings and early adoption of complex cases remain controversial. This study aimed to evaluate perioperative outcomes of robotic ventral hernia repair with early inclusion of complex cases and to compare these results with open surgery. Methods: Prospectively collected data were retrospectively analyzed for consecutive complex robotic ventral hernia repairs performed between September 2021 and December 2025. A cohort of consecutive open Rives–Stoppa repairs was included for comparison (n = 21 per group). Outcomes included operative time, length of hospital stay (LOS), and perioperative complications. Results: Operative time was significantly longer in the robotic group (median 310 vs. 118 minutes, p < 0.001). The median LOS was significantly shorter following robotic repair (3 vs. 5 days, p = 0.0018). Postoperative complications occurred in 10% of robotic cases and 24% of open cases (p = 0.41). Major complications and reoperation rates were low and comparable between groups. Complex robotic cases, including procedures requiring component separation, were introduced early without evidence of worse short-term outcomes. Conclusions: Robotic ventral hernia repair was associated with significantly shorter hospital stay compared with open surgery, despite longer operative times and higher procedural complexity. Complication rates were comparable between groups. Early inclusion of technically complex cases did not compromise short-term outcomes.
- 3 August 2026
- Published by MDPI AG in Preprints.org
Open AccessEarly Adoption of Complex Robotic Ventral Hernia Repair in a Low-Volume Center: A Retrospective Comparative Analysis with Consecutive Open Cases
Background/Objectives: Robotic-assisted abdominal wall reconstruction is increasingly used for complex ventral hernias; however, implementation in low-volume settings and early adoption of complex cases remain controversial. This study aimed to evaluate perioperative outcomes of robotic ventral hernia repair with early inclusion of complex cases and to compare these results with open surgery. Methods: Prospectively collected data were retrospectively analyzed for consecutive complex robotic ventral hernia repairs performed between September 2021 and December 2025. A cohort of consecutive open Rives–Stoppa repairs was included for comparison (n = 21 per group). Outcomes included operative time, length of hospital stay (LOS), and perioperative complications. Results: Operative time was significantly longer in the robotic group (median 310 vs. 118 minutes, p < 0.001). The median LOS was significantly shorter following robotic repair (3 vs. 5 days, p = 0.0018). Postoperative complications occurred in 10% of robotic cases and 24% of open cases (p = 0.41). Major complications and reoperation rates were low and comparable between groups. Complex robotic cases, including procedures requiring component separation, were introduced early without evidence of worse short-term outcomes. Conclusions: Robotic ventral hernia repair was associated with significantly shorter hospital stay compared with open surgery, despite longer operative times and higher procedural complexity. Complication rates were comparable between groups. Early inclusion of technically complex cases did not compromise short-term outcomes.
- Open Access
- 20 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5669
Safe Implementation of Robotic Colorectal Surgery: Balancing Surgical Training and Patient Safety with the Dual-Console System
Background: Robotic platforms expand minimally invasive options in colorectal surgery but raise concerns about training and patient safety. Dual-console systems may enable real-time coaching while preserving outcomes. Methods: We implemented a structured framework for safe implementation of robotic colorectal surgery that balances trainee autonomy with patient safety using a dual-console model. Early cases emphasized low-complexity pathology with escalation by predefined benchmarks. We prospectively gathered data and evaluated early program outcomes with primary endpoints including intraoperative adverse events, conversion to open surgery, 30-day morbidity, anastomotic integrity, and oncologic quality metrics. Secondary endpoints included operative time. Results: We included the analysis of 17 patients operated by one surgeon under supervision and compared the results to other senior colorectal surgeons. Out of the 17 patients, there were no conversions or anastomotic leaks. Overall complications were comparable to baseline robotic cases. Resection margins and lymph node yields met oncologic standards. Operative times were longer during early adoption but approached baseline with progression. Operative times were significantly reduced after eight cases and approached the times of senior surgeons after 13 cases. Conclusions: A dual-console strategy enables safe, scalable training in robotic colorectal surgery without compromising short-term patient outcomes or oncologic quality. Key elements include rigorous case selection, proficiency-based progression, real-time coaching, standardized protocols, and continuous data surveillance. This framework can guide institutions seeking to expand robotic colorectal programs while safeguarding patients and accelerating the learning curve.
- 20 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5669
Open AccessSafe Implementation of Robotic Colorectal Surgery: Balancing Surgical Training and Patient Safety with the Dual-Console System
Background: Robotic platforms expand minimally invasive options in colorectal surgery but raise concerns about training and patient safety. Dual-console systems may enable real-time coaching while preserving outcomes. Methods: We implemented a structured framework for safe implementation of robotic colorectal surgery that balances trainee autonomy with patient safety using a dual-console model. Early cases emphasized low-complexity pathology with escalation by predefined benchmarks. We prospectively gathered data and evaluated early program outcomes with primary endpoints including intraoperative adverse events, conversion to open surgery, 30-day morbidity, anastomotic integrity, and oncologic quality metrics. Secondary endpoints included operative time. Results: We included the analysis of 17 patients operated by one surgeon under supervision and compared the results to other senior colorectal surgeons. Out of the 17 patients, there were no conversions or anastomotic leaks. Overall complications were comparable to baseline robotic cases. Resection margins and lymph node yields met oncologic standards. Operative times were longer during early adoption but approached baseline with progression. Operative times were significantly reduced after eight cases and approached the times of senior surgeons after 13 cases. Conclusions: A dual-console strategy enables safe, scalable training in robotic colorectal surgery without compromising short-term patient outcomes or oncologic quality. Key elements include rigorous case selection, proficiency-based progression, real-time coaching, standardized protocols, and continuous data surveillance. This framework can guide institutions seeking to expand robotic colorectal programs while safeguarding patients and accelerating the learning curve.
- Open Access
- 11 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4538
Safe Introduction of Robotic Gastrectomy Facilitated by ICG-Guided Lymphography
Background/Objectives: Robotic gastrectomy (RG) for gastric cancer requires structured implementation to ensure oncological safety, particularly in Western centers with lower case volumes. Indocyanine green (ICG)-guided near-infrared lymphography may facilitate adequate lymphadenectomy and reliable tumor localization. We report our stepwise institutional introduction of RG and evaluate the perioperative outcomes and diagnostic accuracy of ICG-guided lymphography. Methods: All consecutive patients who underwent curative-intent RG at the University Medical Center Ljubljana between June 2022 and September 2025 were retrospectively analyzed. The implementation followed a structured stepwise approach, beginning with subtotal gastrectomy and progressing to total gastrectomy after formal training at Severance Hospital, Yonsei University Health System, under the mentorship of Prof. Woo Jin Hyung. ICG was administered endoscopically the day before surgery for tumor localization and intraoperative lymphatic mapping. The operative learning curve was assessed by CUSUM analysis, segmented regression, and bootstrapped plateau estimation. Results: Thirty-eight patients underwent RG (17 subtotal and 21 total). R0 resection was achieved in 100% of cases. The conversion rate was 2.6%. Major complications (Clavien–Dindo ≥ IIIb) occurred in six patients (15.8%). The 30-day mortality rate was 0%, and the 90-day mortality rate was 2.6%. Bootstrapped plateau operative times were 321.2 min (95% Bias-corrected and accelerated confidence interval (BCa CI): 278.4–344.1) for subtotal and 413.5 min (95% BCa CI: 378.1–476.1) for total gastrectomy, with the steepest learning phase confined to the first 2–4 cases. ICG was used in 23 patients. In a validation subset of five patients (259 lymph node stations), the sensitivity and negative predictive value were both 100%, with zero false negatives in 57 ICG-negative stations. Conclusions: RG can be safely introduced using a structured, stepwise strategy supported by training at a high-volume expert center. ICG-guided lymphography demonstrated 100% sensitivity for tumor-draining nodal basins in a small validation cohort (n = 5), supporting the feasibility of the technique during program introduction and warranting prospective evaluation in larger series.
- 11 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4538
Open AccessSafe Introduction of Robotic Gastrectomy Facilitated by ICG-Guided Lymphography
Background/Objectives: Robotic gastrectomy (RG) for gastric cancer requires structured implementation to ensure oncological safety, particularly in Western centers with lower case volumes. Indocyanine green (ICG)-guided near-infrared lymphography may facilitate adequate lymphadenectomy and reliable tumor localization. We report our stepwise institutional introduction of RG and evaluate the perioperative outcomes and diagnostic accuracy of ICG-guided lymphography. Methods: All consecutive patients who underwent curative-intent RG at the University Medical Center Ljubljana between June 2022 and September 2025 were retrospectively analyzed. The implementation followed a structured stepwise approach, beginning with subtotal gastrectomy and progressing to total gastrectomy after formal training at Severance Hospital, Yonsei University Health System, under the mentorship of Prof. Woo Jin Hyung. ICG was administered endoscopically the day before surgery for tumor localization and intraoperative lymphatic mapping. The operative learning curve was assessed by CUSUM analysis, segmented regression, and bootstrapped plateau estimation. Results: Thirty-eight patients underwent RG (17 subtotal and 21 total). R0 resection was achieved in 100% of cases. The conversion rate was 2.6%. Major complications (Clavien–Dindo ≥ IIIb) occurred in six patients (15.8%). The 30-day mortality rate was 0%, and the 90-day mortality rate was 2.6%. Bootstrapped plateau operative times were 321.2 min (95% Bias-corrected and accelerated confidence interval (BCa CI): 278.4–344.1) for subtotal and 413.5 min (95% BCa CI: 378.1–476.1) for total gastrectomy, with the steepest learning phase confined to the first 2–4 cases. ICG was used in 23 patients. In a validation subset of five patients (259 lymph node stations), the sensitivity and negative predictive value were both 100%, with zero false negatives in 57 ICG-negative stations. Conclusions: RG can be safely introduced using a structured, stepwise strategy supported by training at a high-volume expert center. ICG-guided lymphography demonstrated 100% sensitivity for tumor-draining nodal basins in a small validation cohort (n = 5), supporting the feasibility of the technique during program introduction and warranting prospective evaluation in larger series.
- Open Access
- 22 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2424
Safety of Simultaneous Robot-Assisted Resection of Colorectal Malignancy and Synchronous Liver Metastases
Introduction: Simultaneous resection of primary colorectal malignancies and liver metastases resulted in outcomes comparable to those achieved through a two-stage procedure, while offering the advantage of a single surgical intervention. The role of the robotic approach remains underexplored because of the lack of comprehensive evidence. The objective of our study was to examine the safety of the robotic surgical platform, assess its short-term outcomes, and compare them with those of open procedures. Methods and Material: We retrospectively analyzed data from an initial small series of eight consecutive patients treated at the UMC Ljubljana between March 2023 and December 2025. These patients underwent robot-assisted simultaneous resection of colorectal malignancies and liver metastases. Their outcomes were compared with those of an open cohort of eight patients. Results: The median operative time was 334 min (range, 193–415 min). No conversions or transfusions were required. Three patients experienced severe complications, accounting for 37.5% of the cohort. The median duration of hospitalization was 9.5 days. The median number of lymph nodes retrieved was 22. Complete (R0) resection of the primary tumor was achieved in all cases (100%), whereas resection of the liver was achieved in 87.5% of the cases. Importantly, there were no instances of re-hospitalization within 30 days or mortality within 90 days. Conclusions: Although the rate of severe complications is relatively high, the robotic surgical platform allows for the safe simultaneous resection of colorectal malignancies and liver metastases, achieving short-term outcomes comparable to those of open surgery.
- 22 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2424
Open AccessSafety of Simultaneous Robot-Assisted Resection of Colorectal Malignancy and Synchronous Liver Metastases
Introduction: Simultaneous resection of primary colorectal malignancies and liver metastases resulted in outcomes comparable to those achieved through a two-stage procedure, while offering the advantage of a single surgical intervention. The role of the robotic approach remains underexplored because of the lack of comprehensive evidence. The objective of our study was to examine the safety of the robotic surgical platform, assess its short-term outcomes, and compare them with those of open procedures. Methods and Material: We retrospectively analyzed data from an initial small series of eight consecutive patients treated at the UMC Ljubljana between March 2023 and December 2025. These patients underwent robot-assisted simultaneous resection of colorectal malignancies and liver metastases. Their outcomes were compared with those of an open cohort of eight patients. Results: The median operative time was 334 min (range, 193–415 min). No conversions or transfusions were required. Three patients experienced severe complications, accounting for 37.5% of the cohort. The median duration of hospitalization was 9.5 days. The median number of lymph nodes retrieved was 22. Complete (R0) resection of the primary tumor was achieved in all cases (100%), whereas resection of the liver was achieved in 87.5% of the cases. Importantly, there were no instances of re-hospitalization within 30 days or mortality within 90 days. Conclusions: Although the rate of severe complications is relatively high, the robotic surgical platform allows for the safe simultaneous resection of colorectal malignancies and liver metastases, achieving short-term outcomes comparable to those of open surgery.
- Open Access
Establishing a Robot-Assisted Liver Surgery Program: Early Experience from University Medical Center Ljubljana
Background and Objectives: Robot-assisted procedures represent a significant advancement in minimally invasive liver resection techniques. Nonetheless, the introduction of a novel surgical technique in a new environment necessitates meticulous planning and a gradual, stepwise approach. This study describes the adoption of a robotic surgical platform for liver resection at a high-volume tertiary care center. Materials and Methods: We retrospectively analyzed data that had been prospectively collected from fifty robot-assisted liver resections. Descriptive statistics, including frequencies, percentages, means/medians, and standard deviations, were employed for description and summary. Results: The median operative duration was 166 min (range: 85–400 min), with an average intraoperative blood loss of 200 mL (range: 50–1000 milliliters). Intraoperative or postoperative blood transfusion was required in 8% of patients. Conversion to open resection was necessary in one patient (2%). The mean duration of hospitalization was 5 days (range: 3–20 days), with a 30-day readmission rate of 6% and no mortality within 90 days. Postoperative complications classified as Clavien-Dindo grade 3 or higher were observed in five patients (10%). The mean tumor size varied according to pathology: 58.5 mm (range: 30–120 mm) in the hepatocellular carcinoma group; 27.4 mm (range: 10–32 mm) in the secondary malignancy group; and 42.6 mm (range: 24–60 mm) in the intrahepatic cholangiocarcinoma group. The median number of lymph nodes harvested during lymphadenectomy (IHHCA/GBCA) was 5.4, ranging from 1 to 11. The R0 resection rate for malignant tumors was 88.2% (of 30/34). Conclusions: This study validates the safe integration of robot-assisted surgery into liver disease treatment, supported by our initial experience. Despite its technical advantages, robotic-assisted liver surgery remains complex and demanding. Structured robotic training within established programs, meticulous patient selection, and a stepwise implementation approach are critical during the early phases to optimize the outcomes.
Open AccessEstablishing a Robot-Assisted Liver Surgery Program: Early Experience from University Medical Center Ljubljana
Background and Objectives: Robot-assisted procedures represent a significant advancement in minimally invasive liver resection techniques. Nonetheless, the introduction of a novel surgical technique in a new environment necessitates meticulous planning and a gradual, stepwise approach. This study describes the adoption of a robotic surgical platform for liver resection at a high-volume tertiary care center. Materials and Methods: We retrospectively analyzed data that had been prospectively collected from fifty robot-assisted liver resections. Descriptive statistics, including frequencies, percentages, means/medians, and standard deviations, were employed for description and summary. Results: The median operative duration was 166 min (range: 85–400 min), with an average intraoperative blood loss of 200 mL (range: 50–1000 milliliters). Intraoperative or postoperative blood transfusion was required in 8% of patients. Conversion to open resection was necessary in one patient (2%). The mean duration of hospitalization was 5 days (range: 3–20 days), with a 30-day readmission rate of 6% and no mortality within 90 days. Postoperative complications classified as Clavien-Dindo grade 3 or higher were observed in five patients (10%). The mean tumor size varied according to pathology: 58.5 mm (range: 30–120 mm) in the hepatocellular carcinoma group; 27.4 mm (range: 10–32 mm) in the secondary malignancy group; and 42.6 mm (range: 24–60 mm) in the intrahepatic cholangiocarcinoma group. The median number of lymph nodes harvested during lymphadenectomy (IHHCA/GBCA) was 5.4, ranging from 1 to 11. The R0 resection rate for malignant tumors was 88.2% (of 30/34). Conclusions: This study validates the safe integration of robot-assisted surgery into liver disease treatment, supported by our initial experience. Despite its technical advantages, robotic-assisted liver surgery remains complex and demanding. Structured robotic training within established programs, meticulous patient selection, and a stepwise implementation approach are critical during the early phases to optimize the outcomes.
- Open Access
- 20 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (20) , 7404
L-FABP as a Potential Biomolecular Marker of Liver Graft Injury
Background: In recent years, indications for liver transplantation have expanded, while the age of transplant recipients has significantly increased due to improvements in perioperative management. As clinical manifestations of posttransplant complications vary and are often nonspecific, the identification of appropriate biomarkers is important for the assessment of graft quality and early recognition of potential complications following liver transplantation. Liver-type FABP (L-FABP) is a small cytoplasmic protein found abundantly in hepatocytes and is involved in the intracellular transport of long-chain fatty acids. Elevated serum levels have been detected in acute and chronic liver failure, kidney failure, and some malignancies. Materials and Methods: We conducted a prospective, single-center study from July 2023 to January 2025, including 29 adult patients who underwent deceased-donor transplantation. Three patients were excluded due to inadequate sample withdrawals. Serum L-FABP was measured preoperatively and on postoperative days 1, 3, 5, 7, and 14. Clinical, surgical, and biochemical data were collected and analyzed using non-parametric statistical tests. Results: L-FABP levels were significantly higher on POD 7 in recipients of grafts from donors ≥ 65 years (p = 0.035), with no corresponding changes in standard liver function markers. While no significant differences in L-FABP levels were found between patients with and without infectious biliary or vascular complications (all p > 0.05), we proved a strong negative correlation between intraoperative blood transfusion volume and L-FABP levels on POD 5 (ρ = −0.677, p < 0.001) and POD 7 (ρ = −0.455, p = 0.025). Conclusions: Our findings suggest that L-FABP holds promise as a biomarker for the early detection of subclinical hepatic graft cellular injury, which is not detected by means of conventional biomarkers for liver function.
- 20 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (20) , 7404
Open AccessL-FABP as a Potential Biomolecular Marker of Liver Graft Injury
Background: In recent years, indications for liver transplantation have expanded, while the age of transplant recipients has significantly increased due to improvements in perioperative management. As clinical manifestations of posttransplant complications vary and are often nonspecific, the identification of appropriate biomarkers is important for the assessment of graft quality and early recognition of potential complications following liver transplantation. Liver-type FABP (L-FABP) is a small cytoplasmic protein found abundantly in hepatocytes and is involved in the intracellular transport of long-chain fatty acids. Elevated serum levels have been detected in acute and chronic liver failure, kidney failure, and some malignancies. Materials and Methods: We conducted a prospective, single-center study from July 2023 to January 2025, including 29 adult patients who underwent deceased-donor transplantation. Three patients were excluded due to inadequate sample withdrawals. Serum L-FABP was measured preoperatively and on postoperative days 1, 3, 5, 7, and 14. Clinical, surgical, and biochemical data were collected and analyzed using non-parametric statistical tests. Results: L-FABP levels were significantly higher on POD 7 in recipients of grafts from donors ≥ 65 years (p = 0.035), with no corresponding changes in standard liver function markers. While no significant differences in L-FABP levels were found between patients with and without infectious biliary or vascular complications (all p > 0.05), we proved a strong negative correlation between intraoperative blood transfusion volume and L-FABP levels on POD 5 (ρ = −0.677, p < 0.001) and POD 7 (ρ = −0.455, p = 0.025). Conclusions: Our findings suggest that L-FABP holds promise as a biomarker for the early detection of subclinical hepatic graft cellular injury, which is not detected by means of conventional biomarkers for liver function.
- Open Access
- 19 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (16) , 2082
Primary Hepatic Mucosa-Associated B-Cell Lymphoma in a Patient with Primary Sclerosing Cholangitis—A Case Ultimately Requiring Liver Transplantation
Background: Primary hepatic extranodal marginal zone lymphoma of mucosa-associated type (MALT) is an extremely rare liver neoplasm. The lesions are often misdiagnosed for the most common primary hepatic malignancy, such as hepatocellular carcinoma and cholangiocarcinoma. As the diagnosis is most often made after the resection, there are still no clear guidelines for the optimal treatment of these patients. Case Presentation: A 30-year-old male patient with known primary sclerosing cholangitis (PSC) was treated at the Department of Abdominal Surgery Ljubljana due to a mass in the right liver, believed to be an intrahepatic cholangiocarcinoma. Due to the extent of the disease, extended right hepatectomy with the resection of the hepatocholedochus, lymphadenectomy, and hepaticojejunal anastomosis were performed. After the surgery, the patient developed a small-for-size syndrome and therefore necessitated a liver transplantation (LT) that was afterwards successfully performed. Discussion: This case highlights the diagnostic challenges of differentiating primary hepatic MALT lymphoma from cholangiocarcinoma on imaging, especially in patients with underlying liver disease. Preoperative confirmation of the malignant disease could potentially change treatment course in our patient. Therefore, a serious surgical complication with development of small-for-size syndrome after major hepatectomy could potentially be prevented. Regarding the underlying liver disease, the patient could probably be a candidate for LT with the bridging chemotherapy. Conclusions: Primary hepatic MALT lymphoma is an extremely rare liver lesion but remains a valid option in a differential diagnosis of liver lesions in patients with chronic viral infection or autoimmune disease, especially in settings of cirrhosis. Moreover, a high level of suspicion must be raised in young patients with solitary liver mass and autoimmune liver disease. Surgical resection is the best way to achieve elimination of the disease.
- 19 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (16) , 2082
Open AccessPrimary Hepatic Mucosa-Associated B-Cell Lymphoma in a Patient with Primary Sclerosing Cholangitis—A Case Ultimately Requiring Liver Transplantation
Background: Primary hepatic extranodal marginal zone lymphoma of mucosa-associated type (MALT) is an extremely rare liver neoplasm. The lesions are often misdiagnosed for the most common primary hepatic malignancy, such as hepatocellular carcinoma and cholangiocarcinoma. As the diagnosis is most often made after the resection, there are still no clear guidelines for the optimal treatment of these patients. Case Presentation: A 30-year-old male patient with known primary sclerosing cholangitis (PSC) was treated at the Department of Abdominal Surgery Ljubljana due to a mass in the right liver, believed to be an intrahepatic cholangiocarcinoma. Due to the extent of the disease, extended right hepatectomy with the resection of the hepatocholedochus, lymphadenectomy, and hepaticojejunal anastomosis were performed. After the surgery, the patient developed a small-for-size syndrome and therefore necessitated a liver transplantation (LT) that was afterwards successfully performed. Discussion: This case highlights the diagnostic challenges of differentiating primary hepatic MALT lymphoma from cholangiocarcinoma on imaging, especially in patients with underlying liver disease. Preoperative confirmation of the malignant disease could potentially change treatment course in our patient. Therefore, a serious surgical complication with development of small-for-size syndrome after major hepatectomy could potentially be prevented. Regarding the underlying liver disease, the patient could probably be a candidate for LT with the bridging chemotherapy. Conclusions: Primary hepatic MALT lymphoma is an extremely rare liver lesion but remains a valid option in a differential diagnosis of liver lesions in patients with chronic viral infection or autoimmune disease, especially in settings of cirrhosis. Moreover, a high level of suspicion must be raised in young patients with solitary liver mass and autoimmune liver disease. Surgical resection is the best way to achieve elimination of the disease.
- Open Access
A Decade-Long Case Series Report on the Surgical Management of Complicated Umbilical Hernia in Patients with Decompensated Liver Cirrhosis Utilizing Incisional Negative Pressure Therapy
Background and Objectives. Umbilical hernia is particularly common among patients with liver cirrhosis, affecting about 20% of this group, compared to 3–8.5% in healthy individuals. This increased prevalence is mainly due to weakened abdominal fascia, elevated intra-abdominal pressure, and malnutrition. The rapid progression of umbilical hernias often leads to complications such as skin necrosis, perforation, and strangulation. Historically, patients with liver cirrhosis and complicated umbilical hernia have faced high morbidity and mortality rates. However, recent advancements in perioperative management, especially in controlling ascites, have improved outcomes in elective treatments. Despite these advancements, managing patients with decompensated liver cirrhosis and complicated umbilical hernia in emergency settings remain a significant surgical challenge. Materials and Methods: We conducted a retrospective review of patients treated for complicated umbilical hernia at the University Medical Centre Ljubljana from 2015 to 2024, using prospectively collected data. This analysis involved implementing hernioplasty combined with incisional negative pressure wound therapy (iNPWT) as part of the surgical protocol. The primary endpoint of our study was the rate of local complications, while the secondary endpoints included the rate of systemic complications and 90-day mortality. Results: We treated 28 consecutive patients with complicated umbilical hernia and liver cirrhosis. Local wound complications were observed in three (10.7%) patients. Systemic complications developed in 10 patients (35.7%). The median duration of hospitalization was 8 days (range: 5–29), and no readmissions were recorded within the 30-day period. Two (7.1%) patients died within 90 days. Conclusions: Our experience indicates that iNPWT, when combined with surgical repair, can be safely utilized, yielding outcomes comparable to elective hernia repairs, even in emergency contexts. Further randomized controlled trials are necessary to validate these findings and optimize treatment protocols.
Open AccessA Decade-Long Case Series Report on the Surgical Management of Complicated Umbilical Hernia in Patients with Decompensated Liver Cirrhosis Utilizing Incisional Negative Pressure Therapy
Background and Objectives. Umbilical hernia is particularly common among patients with liver cirrhosis, affecting about 20% of this group, compared to 3–8.5% in healthy individuals. This increased prevalence is mainly due to weakened abdominal fascia, elevated intra-abdominal pressure, and malnutrition. The rapid progression of umbilical hernias often leads to complications such as skin necrosis, perforation, and strangulation. Historically, patients with liver cirrhosis and complicated umbilical hernia have faced high morbidity and mortality rates. However, recent advancements in perioperative management, especially in controlling ascites, have improved outcomes in elective treatments. Despite these advancements, managing patients with decompensated liver cirrhosis and complicated umbilical hernia in emergency settings remain a significant surgical challenge. Materials and Methods: We conducted a retrospective review of patients treated for complicated umbilical hernia at the University Medical Centre Ljubljana from 2015 to 2024, using prospectively collected data. This analysis involved implementing hernioplasty combined with incisional negative pressure wound therapy (iNPWT) as part of the surgical protocol. The primary endpoint of our study was the rate of local complications, while the secondary endpoints included the rate of systemic complications and 90-day mortality. Results: We treated 28 consecutive patients with complicated umbilical hernia and liver cirrhosis. Local wound complications were observed in three (10.7%) patients. Systemic complications developed in 10 patients (35.7%). The median duration of hospitalization was 8 days (range: 5–29), and no readmissions were recorded within the 30-day period. Two (7.1%) patients died within 90 days. Conclusions: Our experience indicates that iNPWT, when combined with surgical repair, can be safely utilized, yielding outcomes comparable to elective hernia repairs, even in emergency contexts. Further randomized controlled trials are necessary to validate these findings and optimize treatment protocols.